Regeneron Pharmaceuticals, Inc.
Sound Shore initiated Regeneron when the shares traded at roughly 13 times earnings with an 8% free-cash-flow yield. The company has a fortress balance sheet and a pipeline with…
REGN
2 published ideas on Regeneron Pharmaceuticals, Inc. across 2 funds — 2 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Regeneron Pharmaceuticals: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Sound Shore initiated Regeneron when the shares traded at roughly 13 times earnings with an 8% free-cash-flow yield. The company has a fortress balance sheet and a pipeline with…
The fund added to Regeneron because the stock ranked highly on cash flow and forecast earnings measures, two of LSV's most important valuation factors. Management has been…